Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand.
The Australian and New Zealand journal of psychiatry October 1, 2024 Alistair Carroll, Adam Bayes, Mark Montebello et al. 10 citations
Ketamine is a restricted medication in Australia and New Zealand, with regulations that vary by jurisdiction and generally limit its use in patients who have a history of drug dependence. There is substantial variation in how drug dependence is defined legally and clinically, with clinical definitions from the ICD-11 and DSM-5. This paper reviews evidence on the risk of ketamine misuse and dependence among patients with a history of illicit drug use, abuse, or dependence, and offers recommendations for psychiatrists prescribing ketamine for treatment-resistant depression in this population.